Is EC 200-370-5 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EC 200-370-5? Is EC 200-370-5 safe for nursing mother and child? Does EC 200-370-5 extracts into breast milk? Does EC 200-370-5 has any long term or short term side effects on infants? Can EC 200-370-5 influence milk supply or can EC 200-370-5 decrease milk supply in lactating mothers?
EC 200-370-5 lactation summary
- DrLact safety Score for EC 200-370-5 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EC 200-370-5 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EC 200-370-5 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EC 200-370-5 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EC 200-370-5 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EC 200-370-5 usage in lactation
EC 200-370-5 hormone reduces Prolactin serum levels and may likely inhibit milk production mainly soon after delivery. No significant increase of EC 200-370-5 serum levels neither in the mother´s milk nor in the infant’s serum have been found after administration to the mother. No adverse side effects have been noticed in the infant.
Answer by DrLact: About EC 200-370-5 usage in lactation
Limited data indicate that a low-dose (100 mg) subcutaneous EC 200-370-5 pellet given to a nursing mother appears not to increase milk EC 200-370-5 levels markedly. EC 200-370-5 has low oral bioavailability because of extensive first-pass metabolism, so it is unlikely to affect the breastfed infant. One breastfed infant seemed not to be adversely affected by low-dose maternal EC 200-370-5 therapy.
EC 200-370-5 Side Effects in Breastfeeding
An infant (age not stated) was breastfed (extent not stated) after implantation of 100 mg of EC 200-370-5 subcutaneously. No adverse effects were noted in the infant over a 5-month period.[1]
EC 200-370-5 Possible Effects in Breastfeeding
Supraphysiologic serum levels of EC 200-370-5, either from a tumor[2][3] or from exogenously administered EC 200-370-5,[4] reduces milk production in postpartum women. EC 200-370-5 alone reduces serum prolactin;[4] however, when given in combination with estrogen and progestin, serum prolactin levels are not markedly reduced.[5] EC 200-370-5 was previously used therapeutically to suppress lactation, usually in combination with an estrogen.[4][5][6][7][8][9][10]
Alternate Drugs
Testosterone(Low Risk)
Estradiol(Low Risk)
Estradiol Valerate(Low Risk)
Testosterone(Low Risk)
Progesterone(Safe)